Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 31;19(1):2199653.
doi: 10.1080/21645515.2023.2199653. Epub 2023 Apr 17.

Temporal association between COVID-19 vaccination and Raynaud's phenomenon: A case series

Affiliations

Temporal association between COVID-19 vaccination and Raynaud's phenomenon: A case series

Marcus Lisy et al. Hum Vaccin Immunother. .

Abstract

COVID-19 vaccine-related adverse events are mostly minor to moderate, and serious events are rare. Single cases of Raynaud's phenomenon (RP) in temporal proximity to COVID-19 vaccination have been reported. Demographic data, medical history, and detailed information regarding vaccination status and RP characteristics were obtained from patients with confirmed RP after COVID-19 vaccination. Fifteen participants reported the initial manifestation of RP, which occurred in 40% after the first, in 33% after the second, and in 27% after the third vaccination. RP development and occurrence of episodes were not linked to any specific vaccine type. New onset of disease was observed in 40% of the vaccinees after BNT162b2, in 33% after mRNA-1273, and in 27% after ChAdOx1 vaccination. Three out of four participants with preexisting RP prior to COVID-19 vaccination reported aggravation in frequency and intensity after immunization. Although COVID-19 vaccination is pivotal in controlling the pandemic, the observed temporal association between vaccine administration and RP occurrence warrants global activities to support pharmacovigilance for the detection of adverse reactions, one of which may include RP.

Keywords: BNT162b2 vaccine; COVID-19 vaccination; COVID-19 vaccine; ChAdOx1 vaccine; Raynaud’s phenomenon; Raynaud’s syndrome; adverse effect; mRNA-1273 vaccine.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Representative female participant with new onset of Raynaud´s phenomenon after COVID-19 vaccination. a. Well-demarcated, white-pale, cold fourth toe of the right foot. b. Affected index and third finger of the right hand with sharp demarcation of skin pallor. c. Nailfold capillaroscopic image of the affected third finger of the right hand, showing dilatation, torsion and reduced capillary density, but lack of megacapillaries. d and e. Optical pulse oscillograms of the index (d) and the third finger (e) of the affected right hand (red) and the unaffected left hand (blue-green) revealing regular oscillations.

Comment in

References

    1. World Health Organization . WHO coronavirus (COVID-19) dashboard. [accessed 2023 Mar 15]. https://covid19.who.int/.
    1. Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, Giattino C, Rodés-Guirao L.. A global database of COVID-19 vaccinations. Nat Hum Behav. 2021;5(7):947–5. doi:10.1038/s41562-021-01122-8. - DOI - PubMed
    1. Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N.. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022;28(2):202–21. doi:10.1016/j.cmi.2021.10.005. - DOI - PMC - PubMed
    1. Urban N, Weber B, Deinsberger J, Gschwandtner M, Bauer W, Handisurya A. Raynaud’s phenomenon after COVID-19 vaccination: causative association, temporal connection, or mere bystander? Case Rep Dermatol. 2021;13(3):450–6. doi:10.1159/000519147. - DOI - PMC - PubMed
    1. Herrick AL, Wigley FM. Raynaud’s phenomenon. Best Pract Res Clin Rheumatol. 2020;34(1):101474. doi:10.1016/j.berh.2019.101474. - DOI - PubMed